Literature DB >> 33546036

The effectiveness and safety of Chinese herbal formulas on skin photoaging: A protocol for systematic review and meta-analysis.

Ji-Yong He1, Xiao-Yv Yv2, Jing-Dong Wu3, Ling Lv4, Xiao-Qing Zhang4, Tie-Ming Ma4, Yu Zhang4.   

Abstract

BACKGROUND: Skin photoaging (SP) is a complex and complicated process of skin characteristic changes caused by excessive sunlight. Wrinkles, looseness, coarseness, and increase or loss of pigment are the main clinical manifestations of the disease. The pathogenesis of SP mainly involving oxidative stress, inflammatory reaction, immune dysregulation and DNA damage, and so on. In recent years, traditional Chinese medicine, as an significant form of complementary and alternative medicine, has attracted the more and more attention within the field of health care and indicated a desirable effect on SP. Chinese herbal formula (CHF) is an essential part of traditional Chinese medicine interventions, and the number of clinical trails on SP treated by CHFs have shown a growing trend. Therefore, we developed this systematic review and meta-analysis protocol to assess the effectiveness and safety of CHFs in the therapy of SP, so as to provide reliable evidence-based evidence for clinical decision-making.
METHODS: A overall literature retrieval will be carried out in 9 electronic journal database. We will include randomized controlled trials (RCTs) on CHFs alone or combined with routine western medicine measures in the treatment of SP. The outcomes we focused on are consists of symptom score (skin relaxation, telangiectasia, pore coarseness, pigmentation, etc), total effective rate, and adverse reactions. Meta-analysis will be performed using Stata 13.0 software. Literature retrieval and screening, data extraction, risk of bias assessment of RCTs, evidence confidence rating by grading of recommendations assessment, development, and evaluation method and methodological quality assessment of systematic review by assessment of multiple systematic reviews-2 will be conducted independently by 2 reviewers, and disagreements will be resolved through discussion or judged by a third senior reviewer.
RESULTS: This systematic review and meta-analysis will pool the proof of RCTs on SP treated by CHFs alone or combined with conventional western medicine treatments. The findings of this study will be presented at relevant conferences and submitted to peer-reviewed journals for publication.
CONCLUSION: We expect that the results of this systematic review will provide comprehensive and reliable evidence for clinicians and policy makers. REGISTRATION NUMBER: INPLASY 2020120005.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33546036      PMCID: PMC7837906          DOI: 10.1097/MD.0000000000024197

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  26 in total

Review 1.  Photoaging.

Authors:  Barbara A Gilchrest
Journal:  J Invest Dermatol       Date:  2013-07-01       Impact factor: 8.551

2.  [Risk on bias assessment: (2) Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2.0)].

Authors:  Z R Yang; F Sun; S Y Zhan
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2017-09-10

3.  Problems in dealing with missing data and informative censoring in clinical trials.

Authors:  Weichung Shih
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-01-08

4.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

Review 5.  Applicability of evidence from previous systematic reviews on immunotherapy in current practice of childhood asthma treatment: a GRADE (Grading of Recommendations Assessment, Development and Evaluation) systematic review.

Authors:  Erik-Jonas van de Griendt; Mariska K Tuut; Hans de Groot; Paul L P Brand
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

6.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Authors:  Beverley J Shea; Barnaby C Reeves; George Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; Vivian Welch; Elizabeth Kristjansson; David A Henry
Journal:  BMJ       Date:  2017-09-21

Review 7.  Plant extracts and natural compounds used against UVB-induced photoaging.

Authors:  Maria Cavinato; Birgit Waltenberger; Giorgia Baraldo; Carla V C Grade; Hermann Stuppner; Pidder Jansen-Dürr
Journal:  Biogerontology       Date:  2017-07-12       Impact factor: 4.277

8.  Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.

Authors:  Peipei Xue; Yong Wang; Fanfan Zeng; Ruijuan Xiu; Jingwen Chen; Jinguang Guo; Ping Yuan; Lin Liu; Juanjuan Xiao; Hui Lu; Dan Wu; Huaxiong Pan; Mingmin Lu; Feng Zhu; Fei Shi; Qiuhong Duan
Journal:  Oncotarget       Date:  2017-04-18

9.  Comparative effectiveness of 3 Traditional Chinese Medicine treatment methods for idiopathic pulmonary fibrosis: A systematic review and network meta-analysis protocol.

Authors:  Li-Jian Pang; Jian-Ping Liu; Xiao-Dong Lv
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 10.  Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?

Authors:  Lin-Lu Ma; Yun-Yun Wang; Zhi-Hua Yang; Di Huang; Hong Weng; Xian-Tao Zeng
Journal:  Mil Med Res       Date:  2020-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.